A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.

General practitioners across the UK are being asked to help patients offer the gift of life after death by joining the NHS Organ Donor Register (ODR).